|
|
|
|
| LEADER |
01174caa a2200325 ir4500 |
| 001 |
NSK01000366418 |
| 003 |
HR-ZaNSK |
| 008 |
921221s1992 ci ||| ||eng |
| 015 |
|
|
|a HP92-2759
|2 HR
|
| 035 |
|
|
|9 (HR-ZaNSK)366851
|
| 035 |
|
|
|9 (HR-ZaNSK)921221029
|
| 035 |
|
|
|a (HR-ZaNSK)000366418
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 041 |
0 |
|
|a eng
|b scr
|
| 080 |
|
|
|a 615.276.06
|
| 100 |
1 |
|
|a Bingulac-Popović, Jasna
|
| 245 |
1 |
0 |
|a Comparison of protein glycation inhibitory and toxic effects of acetylsalicylic acid in experimental diabetes /
|c Jasna Bingulac-Popović, Dubravka Juretić, Mirko Hadžija, Ivana Čepelak, Dalja Papić-Futač, Milivoje Slijepčević, Krešo Lipovac.
|
| 300 |
|
|
|b Ilustr.
|
| 504 |
|
|
|a Bibliografija: 22 jed
|
| 504 |
|
|
|a Sažetak
|
| 700 |
1 |
|
|a Juretić, Dubravka
|
| 700 |
1 |
|
|a Hadžija, Mirko
|
| 700 |
1 |
|
|a Čepelak, Ivana
|
| 700 |
1 |
|
|a Papić-Futač, Dalja
|
| 700 |
1 |
|
|a Slijepčević, Milivoje
|
| 700 |
1 |
|
|a Lipovac, Krešo
|
| 773 |
0 |
|
|t Acta pharmaceutica (Zagreb)
|x 1330-0075
|g 42 (1992), 3 ; str. 211-218
|w nsk.(HR-ZaNSK)000054908
|
| 932 |
|
|
|a da
|b znanstveni rad
|
| 981 |
|
|
|p CRO
|
| 886 |
0 |
|
|2 unimarc
|b 00975naa2 2200253 450
|